Comments
Japan’s Terumo Corp said on Tuesday it has developed a new syringe that can get seven doses out of each vial of Covid-19 vaccine made by Pfizer Inc, at least one more than accessible with existing syringes.
The Health Ministry approved the design on Friday, and Terumo will begin production at the end of March, a Terumo spokesman told Reuters. The Kyodo News agency, which first reported the development, said Terumo is aiming to make 20 million units this year.
Also read: Syringe shortage hampers Japan's Covid-19 vaccination roll-out
The vaccine made by Pfizer and its German partner BioNTech, is shipped in vials initially indicated to hold five doses. Six doses can be drawn with special syringes, call low dead space, which minimise the amount of vaccine left in the syringe after use.
Japan began its Covid-19 inoculation campaign last month, using Pfizer’s vaccine. Taro Kono, the minister in charge of the effort, said on Friday that some shots may go to waste amid a shortage of the specialty syringes.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.